Skip to main content

Advertisement

SpringerLink
Log in

Low-dose parathyroid hormone and estrogen reverse alkaline phosphatase activity suppressed by dexamethasone in mouse osteoblastic cells

  • ORIGINAL ARTICLE
  • Published:
Journal of Bone and Mineral Metabolism Aims and scope Submit manuscript

Abstract

Glucocorticoid (GC)-induced osteoporosis (GIO) is frequently seen in patients with excessive GC. Numerous questions remain to be clarified about the pathogenesis and treatment of GIO, and the mechanism of GC-inhibited bone formation is not well known. Several studies suggest that parathyroid hormone (PTH) and hormone replacement therapy are effective for GIO. We therefore investigated whether PTH and estrogen would affect cell proliferation and alkaline phosphatase (ALP) activity inhibited by dexamethasone (Dex) in mouse osteoblastic cell-line MC3T3-E1 cells. Low-dose (10−11 M) PTH as well as 10−8 M 17-β-estradiol (17β-E2) significantly attenuated Dex-inhibited ALP activity, although 10−8 M PTH did not affect it. ICI 182780 (10−8 M) antagonized the effects of 17β-E2 on Dex-suppressed ALP activity. Neutralizing anti-IGF-I antibody (3 µg/ml) blocked the reverse effects of 17β-E2 on ALP activity suppressed by Dex. PTH (10−11 M), but not 17β-E2, significantly attenuated [3H]thymidine incorporation inhibited by Dex. On the other hand, PTH and estrogen did not affect the level of 11-β-hydrosteroid dehydrogenase type I mRNA increased by Dex. In conclusion, the present study demonstrated that low-dose PTH and estrogen reversed Dex-inhibited ALP activity in the mouse osteoblastic cell-line.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. TR Dykman OS Gluck WA Murphy TJ Hahn BH Hahn (1985) ArticleTitleEvaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases Arthritis Rheum 28 361–368 Occurrence Handle3872664

    PubMed  Google Scholar 

  2. DW Dempster MA Arlot PJ Meunier (1983) ArticleTitleMean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis Calcif Tissue Int 35 410–417 Occurrence Handle6616314

    PubMed  Google Scholar 

  3. SC Manolagas R Weinstein (1999) ArticleTitleNew development in the pathogenesis and treatment of steroid-induced osteoporosis J Bone Miner Res 14 1061–1066 Occurrence Handle10404005

    PubMed  Google Scholar 

  4. AD Adinoff JR Hollister (1983) ArticleTitleSteroid-induced fractures and bone loss in patients with asthma N Engl J Med 309 265–268 Occurrence Handle6866051

    PubMed  Google Scholar 

  5. EJ Ross DC Linch (1982) ArticleTitleCushing's syndrome-killing disease: discriminatory value of signs and symptoms aiding early diagnosis Lancet 2 646–648 Occurrence Handle10.1016/S0140-6736(82)92749-0 Occurrence Handle6125785

    Article  PubMed  Google Scholar 

  6. CP Bressot J Meunier E Lejeune C Edouard AJ Darby (1979) ArticleTitleHistomorphometric profile, pathophysiology and reversibility of glucocorticoid-induced osteoporosis Metab Bone Disease Res 1 303–311 Occurrence Handle10.1016/0221-8747(79)90024-9

    Article  Google Scholar 

  7. E Canalis (1996) ArticleTitleMechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis J Clin Endocrinol Metab 81 3441–3447 Occurrence Handle10.1210/jc.81.10.3441 Occurrence Handle8855781

    Article  PubMed  Google Scholar 

  8. UA Liberman SR Weiss J Broll HW Minne H Quan NH Bell J Rodriguez-Portules RW Dorns SuffixJr J Pequeker M Favus (1995) ArticleTitleEffect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis N Engl J Med 333 1437–1443 Occurrence Handle10.1056/NEJM199511303332201 Occurrence Handle7477143

    Article  PubMed  Google Scholar 

  9. PN Sambrook (2000) ArticleTitleCorticosteroid osteoporosis: practical implications of recent trials J Bone Miner Res 15 1645–1649 Occurrence Handle10976984

    PubMed  Google Scholar 

  10. GM Hall M Daniels DV Doyle TD Spector (1994) ArticleTitleThe effect of hormone replacement therapy on bone mass in rheumatoid arthritis treated with and without steroids Arthritis Rheum 37 1499–1505 Occurrence Handle7945476

    PubMed  Google Scholar 

  11. MC Hochberg MJ Prashker M Greenward MT Hannan NE Lane SM Lindsay DJ Lovell EA Tindall (1996) ArticleTitleAmerican College of Rheumatology task force on osteoporosis guidelines: recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis Arthritis Rheum 39 1791–1801 Occurrence Handle8912500

    PubMed  Google Scholar 

  12. NE Lane S Sanchez GW Modin HK Genant E Pierini CD Arnaud (1998) ArticleTitleParathyroid hormone treatment can reverse corticosteroid-induced osteoporosis: results of a randomized controlled clinical trial J Clin Invest 102 1627–1633 Occurrence Handle9788977

    PubMed  Google Scholar 

  13. A Gohel G Gronowicz (1996) ArticleTitleGlucocorticoids cause apoptosis in osteoblasts in vitro and in vivo Orthopedic Res Soc 22 183–191

    Google Scholar 

  14. RS Weinstein RL Jilka AM Parfitt SC Manolagas (1998) ArticleTitleInhibition of osteoblastogenesis and promotion of apoptosis by osteoblasts and osteocytes by glucocorticoids J Clin Invest 102 274–282 Occurrence Handle9664068

    PubMed  Google Scholar 

  15. A Gohel MB McCarthy G Gronowicz (1999) ArticleTitleEstrogen prevents glucocorticoid-induced apoptosis in osteoblasts in vivo and in vitro Endocrinology 140 5339–5347 Occurrence Handle10.1210/en.140.11.5339 Occurrence Handle10537165

    Article  PubMed  Google Scholar 

  16. RL Jilka RS Weinstein T Bellido P Roberson AM Parfitt SC Manolagas (1999) ArticleTitleIncreased bone formation by prevention of osteoblast apoptosis with parathyroid hormone J Clin Invest 104 439–446 Occurrence Handle10449436

    PubMed  Google Scholar 

  17. OH Lowry NR Roberts M Wu WS Hixon EJ Crawford (1954) ArticleTitleThe quantitative histochemistry of brain. 2. Enzyme measurements J Biol Chem 207 19–37 Occurrence Handle13152077

    PubMed  Google Scholar 

  18. P Chomccynski N Sacchi (1987) ArticleTitleSingle-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction Anal Biochem 162 156–159 Occurrence Handle10.1016/0003-2697(87)90021-2 Occurrence Handle2440339

    Article  PubMed  Google Scholar 

  19. UC Oppermann KJ Netter E Maser (1995) ArticleTitleCloning and primary structure of murine 11-beta-hydroxysteroid Eur J Biochem 227 202–208 Occurrence Handle10.1111/j.1432-1033.1995.tb20377.x Occurrence Handle7851387

    Article  PubMed  Google Scholar 

  20. M Ernst JK Heath GA Rodan (1989) ArticleTitleEstradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones Endocrinology 125 825–833 Occurrence Handle2752978

    PubMed  Google Scholar 

  21. TK Gray S Mohan TA Linkhart DJ Baylink (1989) ArticleTitleEstradiol stimulates in vitro the secretion of insulin-like growth factors by the clonal osteoblastic cell line, UMR-106 Biochem Biophys Res Commun 158 407–412 Occurrence Handle10.1016/S0006-291X(89)80062-2 Occurrence Handle2916989

    Article  PubMed  Google Scholar 

  22. MS Cooper EH Rabbitt PE Goddard WA Bartlett M Hewison PM Stewart (2002) ArticleTitleAutocrine activation of glucocorticoids in osteoblasts increase with age and glucocorticoid exposure J Bone Miner Res 17 979–986 Occurrence Handle12054173

    PubMed  Google Scholar 

  23. DW Dempster F Cosman M Parisien V Shen R Lindsay (1993) ArticleTitleAnabolic actions of parathyroid hormone on bone Endocr Rev 14 690–709 Occurrence Handle10.1210/er.14.6.690 Occurrence Handle8119233

    Article  PubMed  Google Scholar 

  24. M Nasu T Sugimoto K Chihara (1997) ArticleTitleStimulatory effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on insulin-like growth factor-binding protein-5 mRNA expression in osteoblastic UMR-106 cells: the difference between transient and continuous treatments FEBS Lett 409 63–66 Occurrence Handle10.1016/S0014-5793(97)00484-5 Occurrence Handle9199505

    Article  PubMed  Google Scholar 

  25. T Ishizuya S Yokose H Hori T Noda T Suda S Yoshiki A Yamaguchi (1997) ArticleTitleParathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells J Clin Invest 99 2961–2970 Occurrence Handle9185520

    PubMed  Google Scholar 

  26. JT Swarthout TA Doggett JL Lemker NC Partridge (2001) ArticleTitleStimulation of extracellular signal-regulated kinases and proliferation in rat osteoblastic cells by parathyroid hormone is protein kinase C-dependent J Biol Chem 276 7586–7592 Occurrence Handle10.1074/jbc.M007400200 Occurrence Handle11108712

    Article  PubMed  Google Scholar 

  27. JA Cole (1999) ArticleTitleParathyroid hormone activates mitogen-activated protein kinase in opossum kidney cells Endocrinology 140 5771–5779 Occurrence Handle10.1210/en.140.12.5771 Occurrence Handle10579343

    Article  PubMed  Google Scholar 

  28. LG Raisz (1988) ArticleTitleLocal and systemic factors in the pathogenesis of osteoporosis N Engl J Med 318 818–828 Occurrence Handle3281002

    PubMed  Google Scholar 

  29. JR Seckl BR Walker (2001) ArticleTitleMinireview: 11S61538-hydroxysteroid dehydrogenase type 1-a tissue-specific amplifier of glucocorticoid action Endocrinology 142 1371–1376 Occurrence Handle10.1210/en.142.4.1371 Occurrence Handle11250914

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Endocrinology/Metabolism, Neurology and Hematology/Oncology, Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan

    Mei-Fway Iu, Hiroshi Kaji, Junko Naito, Hideaki Sowa & Kazuo Chihara

  2. Division of Endocrinology/Metabolism and Hematological Oncology, Shimane University School of Medicine, Izumo, Japan

    Toshitsugu Sugimoto

Authors
  1. Mei-Fway Iu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroshi Kaji
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Junko Naito
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hideaki Sowa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Toshitsugu Sugimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kazuo Chihara
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hiroshi Kaji.

About this article

Cite this article

Iu, MF., Kaji, H., Naito, J. et al. Low-dose parathyroid hormone and estrogen reverse alkaline phosphatase activity suppressed by dexamethasone in mouse osteoblastic cells. J Bone Miner Metab 23, 450–455 (2005). https://doi.org/10.1007/s00774-005-0627-2

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00774-005-0627-2

Key words

Search

Navigation